J. Braun et al., TUMOR-NECROSIS-FACTOR-BETA ALLELES AND HYPERINSULINEMIA IN CORONARY-ARTERY DISEASE, European journal of clinical investigation, 28(7), 1998, pp. 538-542
Citations number
17
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
Background Hyperinsulinaemia and dyslipoproteinaemia are markers and r
isk factors for coronary artery disease (CAD) and non-insulin-dependen
t diabetes mellitus (NIDDM). We investigated the influence of a tumour
necrosis factor beta (TNF-beta) gene polymorphism on serum parameters
related to these metabolic disorders in patients with CAD. Methods A
total of 199 patients with CAD and 81 control subjects with angiograph
ically normal coronary arteries were studied. A digestion of amplified
DNA with NcoI revealed three fragment patterns: homozygosity for TNF-
beta1 or TNF-beta*2 and heterozygosity (TNF-beta*1/*2). Results Patie
nts with CAD who had increased serum insulin or C-peptide (fasting and
after glucose load) were predominantly heterozygous for TNF-beta (72%
vs. 47%) and less frequently homozygous for TNF-beta2 (22% vs. 43%,
P=0.03). Conclusion This study demonstrates an association of TNF-beta
alleles with the risk factor hyperinsulinaemia in CAD. Genomic varian
ts of TNF-beta may therefore contribute to the complex susceptibility
for the metabolic syndrome in patients with CAD.